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Salutary role for angiotensin in partial urinary tract obstruction. we found that mice lacking either the angiotensinogen
Background. In the neonatal period, angiotensin II (Ang or angiotensin II (Ang II) type 1 (AT1) receptor gene
II) is up-regulated and induces a timely development of the
fail to develop the renal pelvis and ureteral peristalticrenal pelvis and ureteral peristalsis, thereby protecting the kid-
movement [5]. The anomaly of the urinary tract wasney from hydronephrosis. We tested the possibility that in
adulthood, Ang II may act salutarily on the kidney structure followed by development of hydronephrosis in the up-
during partial urinary tract obstruction by inducing adaptive stream renal parenchyma [5–8]. Thus, during the short
changes in the peristaltic machinery.
perinatal period, Ang II is up-regulated and induces aMethods. Adult male Sprague-Dawley rats were subjected
timely development of the renal pelvis and ureteral peri-to partial unilateral ureteral obstruction (UUO) and divided
into two groups, that is, those treated with (group L, N 5 21) stalsis, thereby protecting the kidney from hydrone-
and those without (group C, N 5 21) an angiotensin type 1 phrosis.(AT1) receptor antagonist (losartan). Control animals were
Later in life, the kidney again may be at risk for devel-sham operated (N 5 10). Rats were sacrificed either at day 7
or day 14. oping hydronephrosis, not because of an increase in urine
Results. The degree of hydronephrosis determined morpho- output this time, but as a result of a mechanical hindrance
metrically was significantly more severe in group L than group produced by stone formation, prostate hypertrophy, neu-C at both day 7 and day 14, indicating that Ang II inhibition
rogenic bladder, etc. Of note, mechanical hindrance ofaccentuated hydronephrosis. The measurement of upstream
pressure within the partially ligated ureter in vivo revealed urine causes a marked up-regulation of the renin-angio-
that losartan significantly attenuates the frequency of ureteral tensin system (RAS) in the adult kidney, as well as in
peristaltic activities. In in vitro studies using ureteral strips the perinatal period [9–13]. Since the AT1 receptor isharvested from normal adult Sprague-Dawley rats (N 5 10),
present on the smooth muscle cells of the ureter [14]Ang II (1028 mol/L) was shown to augment contraction, which
was completely inhibited by losartan (1026 mol/L). and the renal pelvis in adult animals [15], it is plausible
Conclusions. Ang II has a salutary effect of protecting kid- that Ang II may serve in adulthood also to facilitate
neys from hydronephrosis during partial ureteral obstruction
peristalsis during ureteral obstruction and, in so doing,through its ability to augment ureteral peristalsis.
to protect the kidney from hydronephrosis.
This speculation is somewhat odd in light of the well-
established notion that during complete ureteral obstruc-The renal pelvis consists of two layers of smooth mus-
tion, the elevated Ang II contributes to, rather than damp-cles extending from the renal parenchyma to the down-
ens, the renal tubulointerstitial injury, as the injury couldstream ureter and initiates the constant unidirectional
be experimentally ameliorated by the administration ofperistaltic movement of the ureter under the control of
pacemaker cells [1–3]. The renal pelvis develops promptly Ang II receptor antagonists or angiotensin I-converting
during the perinatal period in rodents, when urine output enzyme (ACE) inhibitors [12, 16–22]. Note that the aug-
increases markedly [4], enabling urine to be efficiently mentation of peristalsis in partial obstruction serves to
removed from the kidney. In a recent series of study, dissociate the upstream pressure imposed on the renal
parenchyma from the high downstream pressure. It is
unlikely, therefore, that Ang II’s stimulatory effect on
Key words: hydronephrosis, ureteral peristalsis, losartan, excretion,
peristalsis, even if it exists, can protect the kidney in com-renal pelvis, AT1 gene receptor, parenchymal architecture.
plete obstruction. In partial ureteral obstruction, how-
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Surgical preparation of partial unilateral
ureteral obstruction
Partial UUO was produced according to the method
described previously [23–26] without knowledge of group
assignment (discussed later in this article) by the opera-
tor. Rats were anesthetized (30 mg/kg body weight, intra-
peritoneally; Nembutal, Abbott Laboratories, North Chi-
cago, IL, USA), and a midline longitudinal abdominal
incision was made that permitted access to the left kid-
ney, ureter, and psoas muscle. A 15 mm groove was made
in the psoas. The ureter was placed in it, and the muscle
edges were fit together by ligating three points with 6-0
chromic gut sutures (Ethicon, Inc., Somerville, NJ, USA).
Experimental protocol
Losartan treatment in partial UUO. Animals were di-
vided into three groups: sham-operated rats (group S, N 5
10), partial UUO without treatment (group C, N 5 21),
and partial UUO with the AT1 receptor antagonist losar-
tan (500 mg/L drinking water) from one day prior to the
surgery until sacrifice (group L, N 5 21). The losartan
dose was estimated to be about 60 mg/kg/day based on
the daily volume of drinking water (30 mL/day) [27].
The rats were sacrificed at either 7 days (group S, N 5
5; group C, N 5 14; group L, N 5 14) or 14 days (group
S, N 5 5; group C, N 5 7; group L, N 5 7) after surgery.Fig. 1. Angiotensin II (Ang II) has a direct injurious effect on the renal
parenchyma, which is evident in complete unilateral ureteral obstruction To verify that the volume of water intake and urine
(UUO; that is, severe obstruction). Potentially, Ang II may also have excretion were not affected by losartan, rats were placed
a salutary effect on the renal parenchyma via augmentation of the
in metabolic cages throughout the experimental period.ureteral peristalsis, which is significant only in partial UUO (that is,
mild obstruction). To confirm the effect of losartan, systolic blood pressure
was measured in conscious state by the tail-cuff method
[28] at day 6.
through enhancing ureteral peristalsis (Fig. 1). Of note, Renal angiotensin II contents
the urinary tract obstruction that develops in human
We measured by a radioimmunoassay using a commer-adults is almost always partial in nature.
cial kit (ALPCO, Windham, NH, USA) the Ang II con-In the present study, we tested the possibility that in
tents in the contralateral (N 5 8) and the ipsilateral (N 5adulthood, just as in the perinatal period, Ang II may
8) kidneys of partial UUO and sham-operated kidneysinduce adaptive changes in the peristaltic machinery dur-
(N 5 5). After sacrificing animals by decapitation, kid-ing partial urinary tract obstruction that are salutary for
neys were removed, cleaned of connective tissues in ice-preservation of the renal parenchymal architecture.
cold phosphate-buffered saline (PBS) containing Bestatin
(angiotensinase inhibitor; ALPCO) and immediately ho-
METHODS mogenized with a Polytron (Brinkmann Instruments,
Animals Inc., NY, USA) in 5 mL of ice-cold 0.18 mol/L HCl:etha-
nol (1:3 vol/vol). Ang II was partially purified by theAll experiments were performed on adult male
method of De Silva et al, using extraction column packedSprague-Dawley rats (Harlan Sprague-Dawley, Inc., In-
with phenylsilylsilica (ALPCO) and dried [29].dianapolis, IN, USA) weighing 220 to 260 g. All animals
were housed under standard conditions with unlimited
Histologic studiesaccess to regular rat chow and water. Fifty-two rats were
Kidneys were immersion fixed with 4% buffered para-for histologic studies to examine the effect of losartan
formaldehyde and routinely processed. Three millimetertreatment in partial unilateral ureteral obstruction (UUO).
coronal sections, at the level of the renal hilum includingThirteen rats were used for in vivo assessment of ureteral
the papilla, were prepared and stained with Masson’speristalsis, and 10 rats were used for in vitro study on
isolated ureteral strips. trichrome and by immunohistochemistry.
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Morphometric analyses of the calyx-to-papilla area The expression of a-SMA in the cortical interstitial
ratio and the thickness of pelvic smooth muscle layer area was assessed semiquantitatively by immunoreactiv-
ity for a-SMA. The expression score from 0 to 3 wasTo determine the calyx-to-papilla area ratio, which
based on the intensity and the distribution of a-SMArepresents the degree of hydronephrosis, coronal sec-
immunoreactivity, in which 0 represents no expressiontions were traced with the aid of a camera lucida attach-
other than in blood vessels, 1 represents mild expressionment, and the diameter of papilla and maximum calyceal
(low intensity or ,25% of high intensity), 2 representsspace was measured using a National Institutes of Health
moderate expression (25 to approximately 75% of highImage program [7].
intensity), and 3 represents severe expression (.75% ofThe thickness of pelvic smooth muscle layer was mea-
high intensity) [8, 34].sured by the modified method for arterial wall thickness
described previously [7, 30, 31]. Although the pelvic mus-
Assessment of ureteral peristalsiscle is arranged into two distinct layers, the inner layer
All rats were anesthetized with Inactin (100 mg/kgis much more predominant than the outer layer. The thick-
body wt, intraperitoneally; Byk, Konstanz, Germany) atness of the inner layer was measured on coronal sections
using a computerized planimeter (Micro-plan 2; Don- day 7 after partial UUO without further treatment (N 5
santo Corp., Natick, MA, USA). The thickness of five 16). Following tracheostomy, a polyethylene catheter
randomly selected points was averaged for each rat. (PE-10) was placed into the right jugular vein for contin-
uous infusion of saline (12 mL/hour, N 5 10; 2 mL/h,
Evaluation of cortical interstitial collagen N 5 7) to maintain continuous urinary flow, and laparot-
A standard point-counting method was employed to omy was performed. The dome of the bladder was punc-
quantitate the collagen fractional volume of the cortical tured with a 20-gauge needle to allow free urine outflow,
interstitium on Masson’s trichrome-stained sections as and urine was collected for measuring urine flow rate.
described previously [32]. Under 3400 magnification, The fat pad surrounding the kidney was anchored in
11 nonoverlapping fields were observed. One hundred order to immobilize the left renal pelvis, and the fat
twenty-one points of renal cortex in each field were pad surrounding the pelvis was gently removed. The
counted. Trichrome stain-positive points falling on glo- hydraulic pressure within the ureter was recorded with a
meruli, Bowman’s capsules, or vessels were excluded, continuous recording, servo-null micropipette transducer
while interstitial trichrome-positive points were counted system (model 4A; Instrumentation for Physiology and
as positive. The index of interstitial collagen volume was Medicine, San Diego, CA, USA) as described previously
defined as the number of trichrome-positive points for [35]. After stable rhythmic pulsatile tracing of ureteral
every 1000 points evaluated. pressure was obtained, a single bolus of losartan or saline
(N 5 2) was administrated intravenously (30 mg/kg).Immunohistochemistry
a-Smooth muscle actin (a-SMA) was stained by mono- Isolated ureteral strip
clonal mouse anti-human a-SMA (clone 1A4; Dako, Car- Normal rats were sacrificed (N 5 10), and the isolated
pinteria, CA, USA), 1:3, conjugated with horseradish ureter was cut by transverse incisions into 5 mm strips
peroxidase, incubated for one hour, and developed in
after a removal of adherent fat and connective tissue. The
peroxidase substrate (Research Genetics, Huntsville,
strips were attached to two hooks by 6-0 silk ligatures andAL, USA) for 5 to 10 minutes at room temperature,
mounted under 0.5 g of resting tension in 20 mL organfollowing the manufacturer’s protocol.
baths containing a modified Krebs-Henseleit solutionProliferating cell nuclear antigen (PCNA) was detected
(mmol/L: NaCl 112, KCl 5.9, MgSO4 1.2, CaCl2, 2.5,with monoclonal mouse anti-rat PCNA (clone PC10;
NaHCO3 25.0, NaH2PO4 1.2 and glucose 11.5) at 378CDako), 1:50, using microwave antigen retrieval [33], fol-
and bubbled with 95% O2 and 5% CO2 (pH 7.4). Afterlowed by standard ABC immunostaining (Vectastaint
an equilibration period of 30 minutes, three doses ofABC kit; Vector Laboratories, Burlingame, CA, USA).
Ang II (1027, 1028, and 1029 mol/L), chosen based onTo detect apoptotic cells, the terminal deoxy trans-
previous report [36], were added to the organ bath. De-ferase uridine triphosphate nick end-labeling (TUNEL)
veloped tension was recorded isometrically through amethod was employed by using ApopTagt Peroxidase
force-displacement transducer (model FT.03; Grass In-In Situ Apoptosis Detection Kit (Intergen Co., Purchase,
struments, Quincy, MA, USA) and a polygraph (modelNY, USA) following the manufacturer’s protocol.
7D; Grass Instruments). In some experiments, 5 to 10For each kidney, a-SMA score, PCNA-positive tubu-
minutes after the addition of Ang II, losartan or the Anglar cells, and apoptotic tubular cells of the renal cortex
II type 2 receptor (AT2) antagonist PD123319 (Researchwere counted in 11 fields randomly selected under 3400
Biochemicals Inc., Natick, MA, USA) was administeredmagnification, and the average high-power field (HPF)
values were calculated. at a concentration 100 times higher than that of Ang II.
Fig. 2. (a–c) Coronal sections of kidneys at
day 7. (a) Group S. (b) Group C. (c) Group
L. Black bars indicate 1 mm. (d) Calyx-to-
papilla area ratio. Values are presented as
means 6 SE in group S (h; sham, N 5 5
and 5, days 7 and 14), group C ( ; without
losartan, N 5 14 and 7, days 7 and 14), and
group L ( ; with losartan, N 5 14 and 7, days
7 and 14). The ratio is significantly higher in
the kidneys of group L than those of group
C, indicating that losartan augmented hydro-
nephrosis (**P , 0.01 vs. group S; 1P , 0.05;
11P , 0.01 vs. group C).
Fig. 3. Renal histology after partial UUO.
Mild interstitial mononuclear cell infiltration
and/or fibrotic changes can be observed in
groups C and X at day 7 (Masson’s trichrome
staining; a, b, and c). a-SMA expression (d,
e, and f ) can also be observed in group C and
L, but not conspicuous despite the consider-
able hydronephrosis at day 14. Black bars indi-
cate 0.1 mm. (a and d, group S; b and e, group
C; c and f, group L).
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Statistical analysis significant differences in either indices of interstitial col-
lagen (5.7 6 0.7, N 5 14, vs. 5.8 6 1.1, N 5 14, groupData are presented as means 6 SE. Statistical analysis
C vs. group L, respectively, P 5 NS, at day 7; 8.4 6 2.9,was performed by analysis of variance (ANOVA). Statis-
N 5 7, vs. 7.5 6 1.7, N 5 7, group C vs. group L,tical significance was defined as P , 0.05.
respectively, P 5 NS, at day 14) or the a-SMA score
(0.16 6 0.05, N 5 14, vs. 0.23 6 0.10, N 5 14, group C
RESULTS vs. group L, respectively, P 5 NS, at day 7; 0.40 6 0.16,
N 5 7, vs. 0.50 6 0.16, N 5 7, group C vs. group L,Effects of losartan treatment in partial UUO
respectively, P 5 NS, at day 14).Blood pressure, water intake, and urinary volume. Sys-
Thus, administration of losartan led to augmented hy-tolic blood pressure at day 6 after UUO was significantly
dronephrosis after partial UUO, although the degree oflower in group L (110.4 6 3.3 mm Hg, N 5 10) than in
interstitial injury was comparable between groups.group C (140.0 6 5.4 mm Hg, N 5 10, P , 0.01). Water
However, the tubular epithelial cell proliferation inintake (28.3 6 1.0 mL/day, N 5 10, vs. 30.2 6 0.5 mL/
the renal cortex, as measured by PCNA labeling, wasday, N 5 10, group L vs. group C, respectively, P 5 NS)
reduced by losartan at day 7 (25.1 6 3.9 cells/HPF vs.and urinary volume (12.8 6 1.3 mL/day, N 5 10, vs. 13.7 6
13.7 6 2.1 cells/HPF, group L vs. group C, respectively,1.2 mL/day, N 5 10, group L vs. group C, respectively,
P , 0.01, day 7; 13.7 6 3.3 cells/HPF vs. 7.8 6 1.4 cells/P 5 NS) were similar between these two groups.
HPF, group L vs. group C, respectively, P 5 NS, day
14) in a manner similar to that reported for completeRenal Ang II contents
UUO [17]. The degree of tubular epithelial cell apoptosis
The Ang II level significantly increased in the ipsilat-
in the renal cortex was comparable between groups with
eral kidney of partial UUO (135.6 6 23.8 fmol/g tissue)
versus without losartan (0.38 6 0.04 cells/HPF vs. 0.61 6
compared with the contralateral kidney (69.5 6 18.6
0.27 cells/HPF, group L vs. group C, respectively, P 5
fmol/g tissue, P , 0.05, N 5 8) and the sham-operated NS, day 7; 1.31 6 0.69 cells/HPF vs. 0.59 6 0.09 cells/
kidney (64.7 6 19.7 fmol/g tissue, P , 0.05, N 5 5). HPF, group L vs. group C, respectively, P 5 NS, day 14),
although apoptosis was rarely observed in both groups.Histologic examination of the kidney
The calyx-to-papilla area ratio was significantly higher Histologic examination of the pelvic
in the kidneys of group L than those of group C (1.91 6 smooth muscle layer
0.13, N 5 14, vs. 1.50 6 0.13, N 5 14, group L vs. group At both day 7 and day 14 after surgery, partial UUO
C, respectively, P , 0.05, at day 7; 2.68 6 0.06, N 5 7, caused an increase in the thickness of the pelvic smooth
vs. 1.87 6 0.23, N 5 7, group L vs. group C, respectively, muscle layer and induced hyperplasia of smooth muscle
P , 0.01, at day 14; Fig. 2), indicating that losartan cells (Fig. 4). Neither parameter was significantly differ-
augmented hydronephrosis. ent between group C and group L, indicating that the
Mild interstitial mononuclear cell infiltration and fi- adaptive histologic changes in pelvic smooth muscles
brosis were present in kidneys from both group C and caused by partial UUO are not dependent on Ang II.
group L being compared with group S (Fig. 3 a–c). Al-
though there were no significant differences in the indi- Assessment of ureteral peristalsis in vivo
ces for interstitial collagen by the standard point-count- The observations described previously in this article
ing method between group S and group C (3.6 6 0.5, N 5 raise a possibility that Ang II is involved in the functional
5, vs. 5.7 6 0.8, N 5 14, respectively, P 5 NS, at day 7; adaptive changes of the urinary tract during partial UUO
3.8 6 0.4, N 5 5, vs. 8.4 6 2.9, N 5 7, respectively, P 5 in adults. As shown in Figure 5, during saline infusion
NS, at day 14) or between group S and group L (3.6 6 at the rate of 12 mL/h, the frequency of the ureteral con-
0.5, N 5 5, vs. 5.8 6 1.1, N 5 14, respectively, P 5 NS, traction was significantly attenuated by losartan (19.1 6
at day 7; 3.8 6 0.4, N 5 5, vs. 7.5 6 1.7, N 5 7, respectively, 1.1/min vs. 14.6 6 1.2/min, P , 0.05, N 5 8). Urine flow
P 5 NS, at day 14), the a-SMA score was significantly rate was 2.20 to approximately 3.03 mL/kg/h. Although
higher in group C and L than in group S at day 14 (0.01 6 the difference in amplitude was not significantly different
0.01, N 5 5, vs. 0.16 6 0.05, N 5 14, group S vs. group (11.7 6 1.5 mm Hg vs. 8.8 6 1.5 mm Hg, P 5 NS, N 5 8),
C, respectively, P 5 NS, at day 7; 0.01 6 0.01, N 5 5, the value uniformly decreased in each rat with losartan
vs. 0.40 6 0.16, N 5 7, group S vs. group C, respectively, administration. It was difficult to observe stable ureteral
P , 0.05, at day 14; 0.01 6 0.01, N 5 5, vs. 0.23 6 0.10, peristaltic movement at 2 mL/h saline infusion because
N 5 14, group S vs. group L, respectively, P 5 NS, at of low urine flow rate (,2.0 mL/kg/h). In a small number
day 7; 0.01 6 0.01, N 5 5, vs. 0.50 6 0.16, N 5 7, group of rats, the amplitude (N 5 2) and the frequency (N 5
S vs. group L, respectively, P , 0.05, at day 14; Fig. 3) of the ureteral contraction were stably recorded and
were also partially attenuated by losartan. Upon bolus3 d–f). Between group C and group L, there were no
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Fig. 4. Pelvic smooth muscle at day 7 after partial UUO. Smooth muscles are stained in red, and collagen is stained in blue by Masson’s trichrome
staining (a, group S; b, group C; c, group L), and cell proliferation is shown by anti-PCNA immunostaining (d, group S; e, group C; f, group L).
At both day 7 and day 14 after surgery, partial UUO caused an increase in the thickness of smooth muscle layers (g) and hyperplasia of smooth
muscle cells (h; **P , 0.01 vs. group S). However, neither parameter was significantly different between group C and group L, indicating that the
adaptive histologic changes in pelvic smooth muscles during partial UUO are not dependent on Ang II. Values are presented as means 6 SE in
group S (h; sham, N 5 5 and 5, days 7 and 14), group C ( ; without losartan, N 5 14 and 7, days 7 and 14), and group L ( ; with losartan, N 5
14 and 7, days 7 and 14). The black bars indicate 0.1 mm.
injection of saline alone (N 5 2), during 12 mL/h intrave- respectively), but were not affected by PD1203319 (Fig. 6).
nous saline infusion, neither amplitude nor frequency Thus, Ang II induces ureteral contraction, which is inhib-
changed. itable by an AT1 antagonist.
Assessment of ureteral contraction in vitro
DISCUSSIONTo determine whether Ang II directly regulates ure-
In this study, we studied the early stage of hydrone-teral contraction, we performed in vitro experiments
phrosis secondary to partial UUO of #14 days’ duration,with ureteral strips. Ang II (1027 and 1028 mol/L) induced
since it was reported that there is no further deteriorationcontractile responses of the ureteral strips harvested
in morphology after the first two or three weeks of partialfrom normal adult rats. These responses were completely
abolished by the addition of losartan (1025 and 1026 mol/L, UUO in rats [25, 37]. We have shown that after a week
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Fig. 5. Hydraulic pressures in the ureter before (A) and after (B) losartan administration. Losartan was given at the dose of 30 mg/kg intravenously
(arrow). Losartan attenuated the amplitude and the frequency of ureteral peristaltic activities.
of partial ureteral obstruction, hydronephrosis develops to compensate for the “hydropenic” condition of these
anesthetized, surgically prepared rats. The urine flowas the calyx expands and the papilla becomes atrophic,
and that this hydronephrosis advances as the obstruction rates were 2.20 to approximately 3.03 mL/kg/hour, a
value comparable to that of conscious Harlen Sprague-continues for another week. Of importance, when these
animals were given losartan throughout the duration of Dawley rats reported [27]. This was further confirmed
by in vitro study showing that Ang II induced contractileobstruction, the severity of hydronephrosis quantitated
by the calyx-to-papilla area ratio was appreciably aug- responses in isolated ureteral strips via the AT1 receptor.
These observations are consistent with a previous reportmented, indicating that Ang II plays an adaptive role to
protect the kidney from hydronephrosis. Our observa- in which exogenous Ang II enhances the contractile re-
sponse of the renal pelvis in vivo and in vitro [36]. Ittions are in remarkable contrast to earlier observations
by others in a model of complete ureteral obstruction has been demonstrated that the frequency of ureteral
peristalsis is primarily controlled by the pacemaker sys-showing that pharmacological inhibition of Ang II atten-
uates hydronephrotic changes of the renal parenchyma tem in the proximal portion of the renal pelvis, which
induces constant regular pelvic contraction through[12, 16–22]. Nevertheless, the injurious effect of losartan
found in partial obstruction is in line with our earlier spontaneous action potential [2, 3]. As the urinary flow
rate increases, the frequency of ureteral peristalsis in-findings [5, 8]. Thus, at birth, when animals were exposed
to partial ureteral obstruction because of a marked in- creases to a maximum and reaches that of the pacemaker
system [2, 3]. We found that Ang II enhances the fre-crease in urine output, inhibition of Ang II, genetically
or pharmacologically, leads to hydronephrosis. For neo- quency, as well as the amplitude, of ureteral peristalsis
during partial UUO via the AT1 receptor. It is likelynatal animals, it was clear that an absence of the develop-
ment of ureteral smooth muscles, hence lack of peristaltic therefore that Ang II stimulates the activity of the pace-
maker system during partial UUO, in addition to themovement of urine, underlies the renal parenchymal
damage. direct effect on the contractility of ureteral smooth mus-
cles. It is reasonable to speculate that the AT1 blockadeIn the present study, losartan was shown to attenuate
the frequency of ureteral peristalsis. We chose a seem- caused a loss of functional adaptation in the ureteral
peristalsis, and consequently, hydronephrosis developed.ingly high intravenous infusion rate (12 mL/h) in order
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Fig. 6. In vitro ureteral contraction. (a) 1028 mol/L of Ang II (solid arrow) induced ureteral contractile response. (b) The response was completely
abolished by 1026 mol/L of losartan (open arrow). (c) The response was not affected by 1026 mol/L of PD1203319, an AT2 receptor antagonist
(open arrow). (d) Values of contractile responses (1028 mol/L of Ang II, 1026 mol/L of losartan, or 1026 mol/L of PD1203319) are presented as
means 6 SE.
We have shown that the degree of hydronephrosis was smooth muscles that develop during obstruction. As pre-
sented in the Results section, however, histochemicalsignificantly more severe in losartan-treated than un-
treated animals with partial UUO. In a previous study, and morphometrical analyses revealed no appreciable
effect of Ang II in this regard. Instead, both in vivo andwe demonstrated a high density of Ang II binding site
in the smooth muscle cell layer of the renal pelvis in in vitro studies demonstrated that Ang II has a direct
tonic effect on the contractility of the ureteral smoothrodents, and the binding was markedly reduced by a
simultaneous addition of an excess amount of losartan muscles, which can be effectively inhibited by losartan.
These observations for Ang II are reminiscent of the[5]. This previous study and the present one also demon-
strated the presence of the AT1 receptor—not the AT2 notion that some other vasoactive agents that augment
muscle contractility act as growth factors of cardiac mus-receptor—functionally, that is, Ang II has a significant
biological action on the ureteral smooth muscle in vitro. cle cells of only neonatal animals [38, 39].
The detrimental effect of losartan in partial ureteralSince the renal Ang II level was shown to increase sig-
nificantly in the partial UUO, it is conceivable that Ang obstruction via ureteral peristalsis can be even more
appreciated when one considers that losartan has a directII is carried down from the proximal tubule via urine.
With the earlier results from neonatal animals in mind, protective effect on the renal parenchyma, which was
evident in complete obstruction [12, 16–22]. It is readilywe investigated in the present study the possible role of
Ang II in the hypertrophy or hyperplasia of ureteral presumable therefore that the salutary effect of Ang II
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that develop in neonatal mice during angiotensin inhibition mimicinhibition predominates in mild obstruction, while an
obstructive nephropathy. Kidney Int 55:1683–1695, 1999
injurious effect predominates in severe obstruction (Fig. 9. El-Dahr SS, Gee J, Dipp S, Hanss BG, Vari RC, Chao J: Upregu-
lation of renin-angiotensin system and downregulation of kallikrein1). In the present study, the interstitial injury quantitated
in obstructive nephropathy. Am J Physiol 264:F874–F881, 1993by collagen fractional volume and a-SMA score was not
10. Pimentel JL, Martinez-Maldonado M, Wilcox JN, Wang S, Luo
appreciably affected by losartan, raising the possibility C: Regulation of renin-angiotensin system in unilateral ureteral
obstruction. Kidney Int 44:390–400, 1993that the direct salutary effect of losartan on the renal
11. Pimentel JL Jr, Wang S, Martinez-Maldonado M: Regulationparenchyma, which is evident in complete obstruction,
of the renal angiotensin II receptor gene in acute unilateral ureteral
may be counterbalanced by losartan’s detrimental effect obstruction. Kidney Int 45:1614–1621, 1994
12. Pimentel JL Jr, Sundell CL, Wang S, Kopp JB, Montero A,on the ureteral peristalsis.
Martinez-Maldonado M: Role of angiotensin II in the expressionIn conclusion, this is the first study showing a function-
and regulation of transforming growth factor-beta in obstructive
ally salutary role of Ang II during urinary tract obstruc- nephropathy. Kidney Int 48:1233–1246, 1995
13. Pimentel JL Jr, Montero A, Wang S, Yosipiv I, El-Dahr S,tion in adult animals. That is, by strengthening the peri-
Martinez-Maldonado M: Sequential changes in renal expressionstaltic machinery of the urinary tract, Ang II serves as
of renin-angiotensin system genes in acute unilateral ureteral ob-
a mechanism to protect the renal parenchyma from hy- struction. Kidney Int 48:1247–1253, 1995
14. Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW,dronephrosis.
Bernstein KE: Immunohistochemical localization of rat angioten-
sin II AT1 receptor. Am J Physiol 264:F989–F995, 1993
ACKNOWLEDGMENTS 15. Gasc JM, Shanmugam S, Sibony M, Corvol P: Tissue-specific
expression of type 1 angiotensin II receptor subtypes: An in situThis work was supported by National Institutes of Health grants
hybridization study. Hypertension 24:531–537, 1994DK-44757 and DK-39261. A part of this study was presented in abstract
16. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S: Enala-form at the 32nd Annual Meeting of the American Society of Nephrol-
pril reduces collagen type IV synthesis and expansion of the inter-ogy (November 1999, Miami, FL, USA). Dr. Taiji Matsusaka is a
stitium in the obstructed rat kidney. Kidney Int 45:1637–1647, 1994recipient of a Young Investigator Award from the National Kidney
17. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: An-Foundation. The authors thank Mr. Edward Price, Jr., Ms. Ellen Don-
giotensin II receptor antagonist ameliorates renal tubulointerstitialnert, and Ms. Teresa Bills for technical assistance.
fibrosis caused by unilateral ureteral obstruction. Kidney Int
47:1285–1294, 1995Reprint requests to Iekuni Ichikawa, M.D., Ph.D., MCN C4204,
18. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treat-Departments of Pediatrics and Medicine, Vanderbilt University Medical
ment with enalapril halts tubulointerstitial fibrosis in rats withCenter, Nashville, Tennessee 37232-2584, USA.
obstructive nephropathy. Kidney Int 49:1110–1119, 1996E-mail:iekuni.ichikawa@mcmail.vanderbilt.edu
19. Morrissey JJ, Klahr S: Enalapril decreases nuclear factor kappa
B activation in the kidney with ureteral obstruction. Kidney Int
52:926–933, 1997
APPENDIX 20. Klahr S, Morrissey JJ: Comparative study of ACE inhibitors and
angiotensin II receptor antagonists in interstitial scarring. Kidney
Abbreviations used in this article are: ACE, angiotensin I converting Int 52(Suppl 63):S111–S114, 1997
enzyme; Ang II, angiotensin II; ANOVA, analysis of variance; AT1, 21. Moriyama T, Kawada N, Akagi Y, Ando A, Horio M, Yamauchi
angiotensin II type 1 receptor; AT2, angiotensin II type 2 receptor; A, Nagata K, Imai E, Hori M: TCV-116 inhibits interstitial fibrosis
HPF, high power field; PBS, phosphate-buffered saline; PCNA, prolif- and HSP47 mRNA in rat obstructive nephropathy. Kidney Int
erating cell nuclear antigen; RAS, renin-angiotensin system; a-SMA, 52(Suppl 63):S232–S235, 1997
a-smooth muscle actin; TUNEL, terminal deoxy transferase uridine 22. Morrissey JJ, Klahr S: Differential effects of ACE and AT1
triphosphate nick end-labeling; UUO, unilateral ureteral obstruction. receptor inhibition on chemoattractant and adhesion molecule syn-
thesis. Am J Physiol 274:F580–F586, 1998
23. Ulm AH, Miller F: An operation to produce experimental revers-REFERENCES
ible hydronephrosis in dogs. J Urol 88:337–341, 1962
24. Ichikawa I, Brenner BM: Local intrarenal vasoconstrictor-vasodi-1. Gosling JA, Dixon JS: Species variation in the location of upper
urinary tract pacemaker cells. Invest Urol 11:418–423, 1974 lator interactions in mild partial ureteral obstruction. Am J Physiol
236:F131–F140, 19792. Constantinou CE: Renal pelvic pacemaker control of ureteral
peristaltic rate. Am J Physiol 226:1413–1419, 1974 25. Claesson G, Josephson S, Robertson B: Experimental partial
ureteric obstruction in the newborn rats. IV. Do the morphological3. Constantinou CE, Hrynczuk JR: Urodynamics of the upper uri-
nary tract. Invest Urol 14:233–240, 1976 effects progress continuously? J Urol 130:1217–1222, 1983
26. Kennedy WA II, Stenberg A, Lackgren G, Hensle TW, Sawc-4. Boylan BYJW, Colbourn EP, McCance RA: Renal function in
the foetal and newborn guinea-pig. J Physiol 141:323–331, 1958 zuk IS: Renal tubular apoptosis after partial ureteral obstruction.
J Urol 152:658–664, 19945. Miyazaki Y, Tsuchida S, Nishimura H, Pope Harris RC,
McKanna JM, Inagami T, Hogan BLM, Fogo A, Ichikawa I: 27. Pollock DM, Rekito A: Hypertensive response to chronic NO
synthase inhibition is different in Sprague-Dawley rats from twoAngiotensin induces urinary peristaltic machinery during the peri-
natal period. J Clin Invest 102:1489–1497, 1998 suppliers. Am J Physiol 275:R1719–R1723, 1998
28. Pfeffer JM, Pfeffer MA, Frohlich ED: Validity of an indirect6. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa
T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, Hogan BLM, tail-cuff method for determining systolic arterial pressure in anes-
thetized normotensive and spontaneously hypertensive rats. J LabIchikawa I: Gene targeting reveals a requirement for angiotensin
in the development and maintenance of kidney morphology and Clin Med 78:957–962, 1971
29. De Silva PE, Husain A, Smeby RR, Khairallah PA: Measure-growth regulation. J Clin Invest 96:2947–2954, 1995
7. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishi- ment of immunoreactive angiotensin peptides in rat tissues: Some
pitfalls of angiotensin II analysis. Anal Biochem 174:80–87, 1988mura H, Fogo A, Utsunomiya H, Inagami T, Ichikawa I: Murine
double nullizygotes of the angiotensin type 1A and 1B receptor 30. Matsusaka T, Nishimura H, Utsunomiya H, Kakuchi J, Niimura
F, Inagami T, Fogo A, Ichikawa I: Chimeric mice carrying “re-genes duplicate severe abnormal phenotypes of angiotensinogen
nullizygotes. J Clin Invest 101:755–760, 1998 gional” targeted deletion of the angiotensin type 1A receptor gene:
Evidence against the role for local angiotensin in the in vivo feed-8. Miyazaki Y, Tsuchida S, Fogo A, Ichikawa I: The renal lesions
Fujinaka et al: Ang II in partial UUO 2027
back regulation of renin synthesis in juxtaglomerular cells. J Clin mRNA in the obstructed kidney of rats with unilateral ureteral
ligation. Kidney Int 44:313–321, 1993Invest 98:1867–1877, 1996
31. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, 35. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic
changes vs. hypertrophy in experimental glomerular sclerosis. Kid-Fogo A: Blood pressure-independent effect of angiotensin inhibi-
tion on vascular lesions of chronic renal failure. Kidney Int 42:46– ney Int 35:654–660, 1989
36. Finberg JPM, Peart WS: Function of smooth muscle of the rat55, 1992
32. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I: renal pelvis: Response of the isolated pelvis muscle to angiotensin
and some other substances. Br J Pharmacol 39:373–381, 1970Accelerated fibrosis and collagen deposition develop in the renal
interstitium of angiotensin type 2 receptor null mutant mice during 37. Stenberg A, Jacobsson E, Larsson E, Persson AEG: Long-term
partial ureteral obstruction and its effects on kidney function.ureteral obstruction. Kidney Int 53:937–944, 1998
33. Shi SR, Key ME, Karla KL: Antigen retrieval in formalin-fixed Scand J Urol Nephrol 26:35–41, 1992
38. Cooper G IV: Cardiocyte adaptation to chronically altered load.paraffin-embedded tissues: An enhancement method for immuno-
histochemical staining based on microwave oven heating of tissue Annu Rev Physiol 49:501–518, 1987
39. Cooper G IV, Kent RL, Mann DL: Load induction of cardiacsections. J Histochem Cytochem 39:741–748, 1991
34. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-b1 hypertrophy. J Mol Cell Cardiol 21(Suppl V):11–30, 1989
